Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption

被引:95
作者
Imai, T [1 ]
Imoto, M [1 ]
Sakamoto, H [1 ]
Hashimoto, M [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
D O I
10.1124/dmd.105.004226
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The absorption characteristics of temocapril were investigated using Caco-2 cells, and the esterases expressed in Caco-2 cells were identified. Temocapril was almost completely hydrolyzed to temocaprilat during transport across Caco-2 cells. Hydrolysis experiments of temocapril in Caco-2 cell 9000g supernatant (S9) and brush-border membrane vesicles showed that temocapril was mainly hydrolyzed within the cells after uptake, after which the temocaprilat formed was transported to both the apical and basolateral surfaces. In native polyacrylamide gel electrophoresis by detection of hydrolase activity for 1-naphthylbutyrate, Caco-2 cell S9 showed a band with high esterase activity and another band with extremely low activity. The proteins in the major and minor bands were identified as carboxylesterase-1 (hCE-1) and carboxylesterase-2 (hCE-2). The abundant expression of hCE-1 in Caco-2 cells was supported by reverse transcription-polymerase chain reaction. In the normal human small intestine, hCE-2 is abundantly present, although the human liver expresses much higher levels of hCE-1 and lower levels of hCE-2. The expression pattern of carboxylesterases in Caco-2 cells is completely different from that in human small intestine but very similar to that in human liver. Since the substrate specificity of hCE-1 differs from that of hCE-2, it is suggested that the prediction of human intestinal absorption using Caco-2 cell monolayers should be performed carefully in the case of ester- and amide-containing drugs such as prodrugs.
引用
收藏
页码:1185 / 1190
页数:6
相关论文
共 30 条
[21]   Current progress on esterases: From molecular structure to function [J].
Satoh, T ;
Taylor, P ;
Bosron, WF ;
Sanghani, SP ;
Hosokawa, M ;
La Du, BN .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (05) :488-493
[22]   The mammalian carboxylesterases: From molecules to functions [J].
Satoh, T ;
Hosokawa, M .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 :257-288
[23]   Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver [J].
Schwer, H ;
Langmann, T ;
Daig, R ;
Becker, A ;
Aslanidis, C ;
Schmitz, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 233 (01) :117-120
[24]   Trandolaprilat, an angiotensin-converting enzyme inhibitor, is not excreted in bile via an ATP-dependent active transporter (cMOAT) [J].
Shionoiri, H ;
Takasaki, I ;
Minamisawa, K ;
Ishizuka, H ;
Konno, K ;
Naganuma, H ;
Sasahara, K ;
Kawahara, Y .
HYPERTENSION RESEARCH, 2001, 24 (03) :235-240
[25]  
Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164
[26]  
Takai S, 1997, BIOL PHARM BULL, V20, P869
[27]   Improved passive oral drug delivery via prodrugs [J].
Taylor, MD .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (02) :131-148
[28]   Human and rodent carboxylesterases: Immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression [J].
Xie, MX ;
Yang, DF ;
Liu, L ;
Xue, B ;
Yan, BF .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (05) :541-547
[29]   Species differences in stereoselective hydrolase activity in intestinal mucosa [J].
Yoshigae, Y ;
Imai, T ;
Horita, A ;
Matsukane, H ;
Otagiri, M .
PHARMACEUTICAL RESEARCH, 1998, 15 (04) :626-631
[30]  
Zhang QY, 1999, DRUG METAB DISPOS, V27, P804